|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 700 Pennsylvania Ave SE |
Address2 | 2nd FLoor |
| City | Washington |
State | DC |
Zip Code | 20003 |
Country | USA |
3. Principal place of business (if different than line 2)
| City | Washington |
State | DC |
Zip Code | 20003 |
Country | USA |
|
5. Senate ID# 401104378-24
|
||||||||
|
6. House ID# 435990002
|
||||||||
| TYPE OF REPORT | 8. Year | 2018 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date | 6/30/2018 |
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: Rachael Galoob |
Date | 7/20/2018 10:25:17 AM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BAN
16. Specific lobbying issues
H.R. 2215/S. 1152 - Secure and Fair Enforcement (SAFE) Banking Act of 2017: A bi-partisan bill that provides explicit permission to financial institutions to serve Marijuana Related Businesses, its vendors, and allied businesses without reducing the regulatory requirements under the Bank Secrecy Act or FINCEN Guidance. If enacted, banks would no longer face the threat of federal sanction for working with marijuana-related businesses, entrepreneurs, and allied businesses.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Rachael |
Galoob |
|
N/A |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
H.R. 1810/S. 777 - Small Business Tax Equity Act of 2017: The legislation will repeal the tax penalty that singles out state-legal marijuana businesses and bars them from claiming deductions and credits.
Under current federal law, marijuana is classified as a Schedule I controlled substance under the federal Controlled Substances Act (CSA).
As a result, businesses in states with legalized marijuana may not deduct the usual expenses a small business incurs.
This bill would create an exception to IRC section 280E to allow business operating in compliance with state law to claim the same deductions and credits as any other legal business.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Rachael |
Galoob |
|
N/A |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MED
16. Specific lobbying issues
PROTECT AND EXPAND PATIENTS - including Veterans - Access to Medical Cannabis
Since 2014, Congress has restricted the U.S. Department of Justice from spending appropriated funds that interfere with a states implementation of its legal Cannabis programs. This language remains the law today following passage of FY2018 Omnibus Appropriations Act. Further, the House Appropriations Committee recently voted to include language protecting medical Cannabis programs from federal interference within the base text of the FY2019 Commerce, Justice, Science and Related Agencies Appropriations Bill.
Congress commitment to maintain this longstanding policy comports with the April 2018 poll by Quinnipiac University that found 70% of Americans oppose federal government interference in states that have enacted Cannabis programs. Americans do not think the federal government should try to prohibit the sale and use of Cannabis in the states where it has been legalized. Protecting access to Cannabis as medicine may also be an option as the country looks to address the opioid epidemic. Studies published in Health Affairs found that use of prescription opioids decreased in states with legal medical medical programs.
Research into the potential benefits of medical Cannabis as an alternative to opiods - and other medications - is particularly critical for Americas veterans who often lack effective treatments for their complicated, service-related injuries and illnesses. The passage of H.R. 5520 - the VA Medicinal Cannabis Research Act of 2018 - in April 2018 authorized the Department of Veterans Affairs (VA) to advance scientific and medical research into the safety and efficacy of medical cannabis usage by veterans with diagnoses such as post-traumatic stress disorder (PTSD) and chronic pain. This is a critical step toward offering broader choices for treatment to service members, but it is only a first step. We need to continue to support not only the research of, but also the access to, medical Cannabis for veterans in an effort to provide them with the best care that this country can provide.
Endorsed Legislation:
Continuation of the Joyce | Leahy Amendment in the Appropriations Process
H.R. 331 - States Medical Marijuana Property Rights Protection Act
H.R. 1820 - Veterans Equal Access Act
H.R. 2273 - Charlottes Web Medical Access Act of 2017
H.R. 2920/S.1374 - Compassionate Access, Research Expansion, and Respect States (CARERS) Act of 2017
H.R. 1824/S. 780 - Responsibly Addressing the Marijuana Policy Gap Act of 2017
H.R. 5220 - The VA Medicinal Cannabis Research Act of 2018
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Rachael |
Galoob |
|
N/A |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address |
|
||||||
| City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
| City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
3 |
|
||||||
| 2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |